Introduction
Pachyonychia congenita (PC) describes a group of rare autosomal dominant skin disorders characterized predominantly by dystrophic, thickened nails and painful and highly debilitating palmoplantar hyperkeratosis. [1, 2] Müller made one of the first documented observations of PC in 1904. [3] The next reports were published in 1905 by Wilson[4] and in 1906 by Jadassohn and Lewandowsky. [5] With a base on phenotypes, PC is classified in four types: PC I to III and PC tarda. [6, 7] The objective of this case report is to describe the clinical features of PC-I. Although with inherent limitations of a single case, this report may contribute to better understanding about this rare condition.
Case Report
A 9-year-old male born at term to non consanguineous parents was referred to our outpatient clinic for evaluation of thickened nails starting at the age of 6 months.
Pathogenesis

Genetic Diagnosis
He presented with history of pinhead-sized yellowish spiny skin lesions all over body noted at birth that had slowly grown during the first year of age and abnormalities nails. No history of natal or neonatal teeth was there. The patient intelligence was normal. No similar complaints in family.
Physical examination showed:
Skin: Multiple follicular discrete papules present over the face, upper chest, buttock, elbow, knees and flexures [Figures 1 and 2] All 20 nails were thickened, yellowish discoloration with increased curvature and subungual hyperkeratosis Focal plantar keratoderma [ Figure 6 ] Oral mucosa: Mucosal leucokeratosis [ Figure 7 ] There were no abnormalities in examination of palms, otolarynx and ophthalmology.
All laboratory investigations were within normal limits. KOH mounts of toe and finger nails were negative for fungal elements. Histopathology examination of Follicular keratotic papule showed follicular plugging, hyperkeratosis and acanthosis. A skin biopsy of sole showed marked hyperkeratosis, acanthosis, moderate hypergranulosis and minimal dermal inflammatory infiltration. Based on characteristic clinical findings and histopathology features, diagnosis of PC type 1 or Jadassohn-Lewandowski syndrome was confirmed.
Discussion
PC is a rare, autosomal dominant disorder characterized by triad of subungual hyperkeratosis with accumulation of hard keratinous material beneath the distal portion of the nails, lifting the nails from the nail bed, keratosis palmaris et plantaris with thick callosities, especially on the soles and thick white areas on the oral mucosa. [8] Other associated features which may occur include keratosis pilaris, hyperkeratotic follicular papules on the sites of friction, hair abnormalities and hyperhidrosis of the palms and soles. These disorders have been suggested to be due to mutations in paired keratins, K6a/K16 (in PC1) and K6b/K17 (in PC2). According to these mutations, various clinical variants have been described: PC-I or Jadassohn-Lewandowski syndrome (MIM #167200) is a common entity characterized by onychogryposis on all the digits (100%), hyperkeratosis of the palmo plantar (50-90%) and of extensor areas, follicular keratosis (37%), oral (50-75%) or laryngeal (6-15%) leukokeratosis, acral hyperhidrosis (20-75%) and blisters (36%). [5, 6, 7, 8, 9, 10, 11, 12] In patients with PC-II or Jackson-Lawler syndrome (MIM #167210), main changes are natal or neonatal teeth (15-50%), cutaneous cystic lesions (25%), disorders in scalp and eyebrow hairs (9-25%), in addition to corneal dystrophy (8%); moreover, the nail hyperkeratosis is less accentuated in PC-II than in PC-I. [6, 9, 10, 11, 12] PC-III (Schafer-Brunauer syndrome) shows combined features of type 1 and 2 with angular cheilosis, cataract and corneal dyskeratosis. [7] Despite recent advances in genetic analysis, misdiagnosis can occur because same mutations may show diverse features.
A fourth variant, PC tarda, has also been described and is characterized by a later onset that ranges from late childhood to middle ages. Other rare variants include PC with only nail involvement.
Keratins are structural proteins that promote the integrity of epithelial cells. As a result, mutations in the genes encoding keratins lead to cell fragility. [1] The skin expresses the largest number of keratin genes of any organ in body. PC is caused by mutations in five keratin genes KRT6a, KRT6b, KRT6c, KRT16 and KRT17 which are expressed only in palmo plantar skin, the nail bed, pilosebaceous unit and oral mucosa, leading to selective involvement of these sites in PC. [1] PC is an autosomal dominant disorder. More than 45% of cases appear spontaneously with no family history of PC. Given the overlapping clinical presentation with other genetic disorders, only genetic testing can confirm the PC diagnosis.
With nearly 100 distinct PC mutations now identified, correlating the signs of PC with specific mutations
Histological Findings
Treatment
and genes has led to a new classification system of PC, now classified into five subgroups corresponding to the underlying genetic defect: PC-K6a, PC-K6b, PC-K6c, PC-K16 and PC-K17.
Histological examination of plantar hyperkeratosis plaques reveals an acanthotic epidermis with parakeratosis and orthokeratosis compatible with rapid keratinocyte proliferation and differentiation. Cytologic atypical is not seen.
Complications like respiratory distress due to laryngeal leucokeratosis and acroosteolysis, malignant changes in palmoplantar lesions can occur in PC.
Treatment options for PC fall into four broad categories:
Non-invasive (mechanical) e.g. abrasion with some hand tool Invasive (surgical) e.g. electrofulgration, excision Chemical methods using urea, propylene glycol, alpha hydroxy acid Pharmacological (vitamin A, retinoid), all basically targeted at reducing the hyperkeratosis involving different sites.
When the familial mutation is known, genetic counseling can be done and if required, prenatal diagnosis can be done at early stage of pregnancy by chorionic villi biopsy. In our case, we advised keratolytics and oral isotretinoin.
Conclusion
PC is a rare genetic disorder for which there are very few therapeutic options available. Free genetic testing is provided to each patient through the International Pachyonychia Congenita Research Registry (IPCRR) sponsored by the PC Project (www.pachyonychia.org) which is a non-profit USA public charity, supports clinical and research activities related to the treatment of pachyonychia congenital. In India, we don't have such projects working on PC. With this case, we intend to draw attention to this condition and the role of the dermatologist in the diagnosis.
What is new?
Pachyonychia congenita is a rare genodermatosis due to mutations in one of four keratin genes. To the best of our knowledge this represents the first report of isolated PC with healthy other siblings and parents. 
